Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
about
Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)Vilanterol and fluticasone for asthmaA re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary diseaseCan the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?Potentiated interaction between ineffective doses of budesonide and formoterol to control the inhaled cadmium-induced up-regulation of metalloproteinases and acute pulmonary inflammation in ratsInvestigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease.Vilanterol and fluticasone furoate for asthma.Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials.Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.QVA149 (indacaterol/glycopyrronium fixed-dose combination): a review of its use in patients with chronic obstructive pulmonary disease.Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.Bronchodilators, receptors and cross-talk: Together is better?Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis.The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma.Safety of inhaled long-acting anti-muscarinic agents in COPD.Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.Characteristics of newly diagnosed COPD patients treated with triple inhaled therapy by general practitioners: a real world Italian study.Hydrodehalogenation of alkyl iodides with base-mediated hydrogenation and catalytic transfer hydrogenation: application to the asymmetric synthesis of N-protected α-methylamines.A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease.A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD.Response of exhaled nitric oxide to inhaled corticosteroids in patients with stable COPD: A systematic review and meta-analysis.
P2860
Q24186189-B2D40740-FE20-4BCC-B37E-9E3DDDDF1406Q24197900-5376D300-BC5B-4AEB-A797-4A3D21B60F1FQ26801661-951569BE-7B05-442E-BABF-4CDD45ED7D38Q28391808-52138465-8666-4D7C-A784-719482ACAB44Q28654717-CD174356-D33A-431A-BB51-50D69C9FF139Q30397854-3F3012A1-34EF-4D49-9D2E-E4DE370155F0Q34539126-E20B8C8A-9403-48CF-A4FA-AAB023FB5F86Q34686851-834B208D-EF80-4AFE-A1E4-9280DCFFCE4FQ35965128-67DEFEF0-7895-4627-8B5A-856047052350Q38194114-74175BC9-1D3F-4FB2-9B62-093950449B3CQ38209833-D597A560-B5C6-45AA-AAAF-5E228CFA1824Q38570698-90D9603E-53FC-48D2-8784-161491922262Q38690660-982F7A40-2CA3-4CA5-8344-337A0BA4BB00Q38827675-52C54149-D156-4396-96E7-C307D267E27AQ38947467-EC0A5FA4-B010-4CA6-ACC4-E1D0F1A62739Q39232425-7966EF27-3D8B-40AE-B236-CDE990759900Q39782286-9E2DF219-3F3A-426D-8368-1E4C3AD40586Q40052187-AC264D13-4138-4675-9A0A-B821B085B88BQ42758193-23D56443-42A7-4DE7-BCFA-8701A720F1EAQ45930166-F81EC50B-6DAB-4934-B124-1175286649A9Q47664891-B88742D7-85F2-4FED-A56C-8A65A49AB10DQ51503891-DE8FAC90-431A-4E0A-AC25-5305AF0DC58D
P2860
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
@en
type
label
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
@en
prefLabel
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
@en
P50
P1476
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD
@en
P2093
P304
P356
10.2174/0929867311320120003
P577
2013-01-01T00:00:00Z